Translating the ABCS Into HIV Care (ABCSinHIV)

University of Rochester

Status

Completed

Conditions

HIV

Cardiovascular Risk Factor

Treatments

Behavioral: ABCS training

Study type

Interventional

Funder types

Other

NETWORK

NIH

Identifiers

NCT03902431

U01HL142107

Details and patient eligibility

About

The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.

Full description

Our project has two major aims:

Aim 1: To assess the impact of the implementation of an evidence-based, multilevel strategy to reduce cardiovascular vascular disease (CVD) among PLH.

Aim 2: To assess the process of implementation of these strategies using RE-AIM QuEST. Using both quantitative and qualitative methods, we evaluate the process of implementation by assessing Reach, [Effectiveness addressed in Aim 1], Adoption, Implementation and Maintenance whilst integrating Qualitative Evaluation for Systematic Translation.

Enrollment

4,277 patients

Sex

All

Ages

40 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Sites:

Serve a cohort of at least 100 HIV patients
Have an Electronic Health Record (EHR)
Agree to collaborate on implementing feasible adaptations of intervention strategies

Patients:

Patient of the site with a diagnosis of HIV
Age 40-79 years
≥5% risk for CVD as calculated using the ASCVD Risk Estimator Plus
Willing to participate
No plans to leave the site in the next 12 months
Proficient in either English or Spanish
Own a cell phone with texting capabilities

Clinicians:

Physicians, Physicians Assistants, or Nurse Practitioners who provide direct HIV care to patients
Work at a participating site
Willing to implement the project's intervention strategies

Exclusion criteria

Patients:

Currently participating in another CVD trial
Have experienced a prior cardiac or vascular event such as myocardial infarction (MI) or cerebrovascular accident (CVA)
Have had a CVD procedure such as installation of a stent or angioplasty
Have peripheral vascular disease, intermittent claudication or peripheral arterial disease
Are pregnant
Lacks capacity to consent

Clinicians:

• Planning to leave the site within the next 12 months